STREXIT2 at the EU Cancer Mission’s 5th Anniversary Event: Stronger Through Connection
From 29 September to 1 October 2026, the STREXIT2 consortium was represented at “5 Years EU Cancer Mission: Stronger Through Connection” in Brussels, Belgium. Organised by the European Commission, the event marked five years of the EU Cancer Mission and brought together researchers, clinicians, policymakers, patient representatives, innovators and other stakeholders to reflect on progress […]
Bringing Research Closer to Patients: How Pragmatic Trial Designs Can Transform Rare Cancer Research
Traditional clinical trials are essential for determining whether new treatments are safe and effective. However, the highly controlled conditions that make these trials rigorous can also make participation difficult. Strict eligibility criteria, frequent hospital visits, additional tests and, often, the need to travel to specialist centres may prevent many patients from taking part. (Adashek and Kurzrock, 2023) These barriers are […]
Exploring Clinical Innovation: A New Blog Series
We are happy to announce a new blog series created in collaboration between the Sarcoma Patient Advocacy Global Network (SPAGN) and the STREXIT 2 Project. In 2026, the series will explore key topics in clinical research, including international collaboration in rare cancer research, the role of Horizon Europe in driving innovation, the integration of real-world […]
The objectives of the STREXIT 2 Project in the words of Principal Investigator and Co-Leader Dr Winan van Houdt
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part of the EU Mission on Cancer. The twelve clinical trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster.
Introducing the Clinical Trial leaders of the STREXIT2 Project
Over the last couple of months, we introduced the people and organisations behind the STREXIT2 Project on our social media platforms. In this article, we will focus on the project’s clinical trial leader, Prof. Dr Alessandro Gronchi and the clinical trial co-leader, Dr Winan van Houdt. Dr Alessandro Gronchi, MD, graduated with high honours from […]
